The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.

Spectral speech features may serve as noninvasive biomarkers for monitoring attention and executive function in major depressive disorder.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

A smartwatch system helps parents shorten and defuse children's severe tantrums by providing real time behavioral intervention strategies.

A set of 6 distinct midlife depressive symptoms appear to be associated with an increased risk for dementia later in life.